ERBB2 and neoplasm: While TNBC is typically considered one of the most aggressive subtypes due to its lack of hormone receptors and HER2 expression [27], the absence of a significant correlation between budding and molecular markers may indicate that tumor budding represents a distinct pathological feature that transcends molecular classifications.